IBDEI1HK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25221,1,3,0)
 ;;=3^Huntington's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25221,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,25221,2)
 ;;=^5003751^F02.80
 ;;^UTILITY(U,$J,358.3,25222,0)
 ;;=G90.3^^95^1143^25
 ;;^UTILITY(U,$J,358.3,25222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25222,1,3,0)
 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,25222,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,25222,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,25223,0)
 ;;=G91.2^^95^1143^26
 ;;^UTILITY(U,$J,358.3,25223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25223,1,3,0)
 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25223,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,25223,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,25224,0)
 ;;=G91.2^^95^1143^27
 ;;^UTILITY(U,$J,358.3,25224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25224,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavorial Disturbances
 ;;^UTILITY(U,$J,358.3,25224,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,25224,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,25225,0)
 ;;=G30.8^^95^1143^2
 ;;^UTILITY(U,$J,358.3,25225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25225,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,25225,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,25225,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,25226,0)
 ;;=A81.89^^95^1143^6
 ;;^UTILITY(U,$J,358.3,25226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25226,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,25226,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,25226,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,25227,0)
 ;;=F19.97^^95^1143^35
 ;;^UTILITY(U,$J,358.3,25227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25227,1,3,0)
 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
 ;;^UTILITY(U,$J,358.3,25227,1,4,0)
 ;;=4^F19.97
 ;;^UTILITY(U,$J,358.3,25227,2)
 ;;=^5003465
 ;;^UTILITY(U,$J,358.3,25228,0)
 ;;=G20.^^95^1143^28
 ;;^UTILITY(U,$J,358.3,25228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25228,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25228,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25228,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,25229,0)
 ;;=G20.^^95^1143^29
 ;;^UTILITY(U,$J,358.3,25229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25229,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,25229,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25229,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,25230,0)
 ;;=G23.1^^95^1143^34
 ;;^UTILITY(U,$J,358.3,25230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25230,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,25230,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,25230,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,25231,0)
 ;;=F03.91^^95^1143^15
 ;;^UTILITY(U,$J,358.3,25231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25231,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25231,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,25231,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,25232,0)
 ;;=F03.90^^95^1143^17
 ;;^UTILITY(U,$J,358.3,25232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25232,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25232,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,25232,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,25233,0)
 ;;=F06.30^^95^1144^2
 ;;^UTILITY(U,$J,358.3,25233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25233,1,3,0)
 ;;=3^Depressive Disorder d/t Another Medical Condition,Unspec
